Cargando…
Inhaled therapy reduces COPD mortality
Plotting exacerbation rate versus mortality rate for the treatment groups in two recent controlled trials investigating triple therapy in COPD, there is a significant positive correlation supporting a positive impact of inhaled therapy on mortality https://bit.ly/35jbEiN
Autores principales: | Andreas, Stefan, Taube, Christian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7701338/ https://www.ncbi.nlm.nih.gov/pubmed/33294425 http://dx.doi.org/10.1183/23120541.00634-2020 |
Ejemplares similares
-
Risk of all-cause mortality or hospitalization for pneumonia associated with inhaled β2-agonists in patients with asthma, COPD or asthma-COPD overlap
por: Amegadzie, Joseph Emil, et al.
Publicado: (2022) -
Inhaled corticosteroids and angiotensin-converting enzyme-2 in COPD
por: Lipworth, Brian, et al.
Publicado: (2021) -
Treatment of COVID-19 by Inhaled NO to Reduce Shunt?
por: Hedenstierna, Göran, et al.
Publicado: (2020) -
Inhalation therapy in mechanical ventilation
por: Rocha, Ângelo Roncalli Miranda, et al.
Publicado: (2016) -
COPD mortality and exacerbations in the placebo group of clinical trials over two decades: a systematic review and meta-regression
por: Andreas, Stefan, et al.
Publicado: (2022)